Bristol-Myers Squibb Co
NYSE:BMY
Operating Margin
Bristol-Myers Squibb Co
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | US |
Market Cap | 88.8B USD |
Operating Margin |
24%
|
Country | JP |
Market Cap | 776 550.9T JPY |
Operating Margin |
-83%
|
Country | US |
Market Cap | 741.6B USD |
Operating Margin |
30%
|
Country | DK |
Market Cap | 4T DKK |
Operating Margin |
45%
|
Country | UK |
Market Cap | 440.4B GBP |
Operating Margin |
3%
|
Country | JP |
Market Cap | 82T JPY |
Operating Margin |
6%
|
Country | US |
Market Cap | 350.3B USD |
Operating Margin |
29%
|
Country | US |
Market Cap | 330.5B USD |
Operating Margin |
7%
|
Country | UK |
Market Cap | 187B GBP |
Operating Margin |
19%
|
Country | CH |
Market Cap | 182.4B CHF |
Operating Margin |
27%
|
Country | CH |
Market Cap | 176B CHF |
Operating Margin |
32%
|
Profitability Report
View the profitability report to see the full profitability analysis for Bristol-Myers Squibb Co.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Bristol-Myers Squibb Co's most recent financial statements, the company has Operating Margin of 24.1%.